Microbot Medical Inc.
MBOT
$2.61
$0.187.41%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 170.81% | 33.05% | 14.08% | -6.68% | -18.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 65.86% | 29.72% | 8.05% | -18.33% | -32.59% |
| Operating Income | -65.86% | -29.72% | -8.05% | 18.33% | 32.59% |
| Income Before Tax | -7.55% | -31.44% | -7.78% | 16.89% | -5.20% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.55% | -31.44% | -7.78% | 16.89% | -5.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.55% | -31.44% | -7.78% | 16.89% | -5.20% |
| EBIT | -65.86% | -29.72% | -8.05% | 18.33% | 32.59% |
| EBITDA | -67.44% | -29.83% | -8.66% | 18.59% | 33.01% |
| EPS Basic | 25.94% | 6.56% | 33.23% | 52.61% | 31.43% |
| Normalized Basic EPS | -14.48% | 6.58% | 33.20% | 52.63% | 55.57% |
| EPS Diluted | 25.94% | 6.56% | 33.23% | 52.78% | 31.43% |
| Normalized Diluted EPS | -14.48% | 6.58% | 33.20% | 52.63% | 55.57% |
| Average Basic Shares Outstanding | 45.18% | 40.69% | 61.40% | 75.41% | 53.43% |
| Average Diluted Shares Outstanding | 45.18% | 40.69% | 61.40% | 75.41% | 53.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |